Products

Carbidopa/Levodopa IR Tablets

Approval Status
EU:
Approved I USA: Being filed in Jan’17
Canada: Approved I Australia: Being filed in May ’16
Other Markets: Being filed
Telmisartan Tablets

Approval Status
EU:
Approved I USA: Being filed in Jul’17
Canada: Approved
Other Markets: Being filed in Ukraine
LevoCetirizine Di HCL Tablets

Approval Status
EU:
Approved I USA: Under Review
Other Markets: Filed in Ukraine
Cetirizine Di HCL Tablets

Approval Status
EU:
Approved I USA: Ready To File
Canada: Approved I Australia: Filed in Feb'16
Other Markets: Filed in SA
Raloxifene HCL Tablets

Approval Status
EU:
Approved I Australia: Approved
Other Markets: Being filed in June’16
Amlodipine Tablets

Approval Status
EU:
Approved
Clopidogrel Besylate Tablets

Approval Status
EU:
Approved
S(-) Amlodipine Basilate Tablets

Approval Status
Other Markets:
Filed in Ukraine
Telmisartan/HCT Tablets

Approval Status
EU:
Under review I USA: Being filed in Jul'17
Other Markets: Being filed in Ukraine & SA
Telmisartan/Amlodipine Tablets

Approval Status
EU:
Being filed in Dec'16 I Canada: Under review
Australia: Filed in May'16
Other Markets: Being filed in Ukraine & SA
Carbidopa/Levodopa ER Tablets

Approval Status
EU:
Being filed in Dec'16 I USA: Under Development
Olmesartan Medoxomil Tablets

Approval Status
EU & USA:
Expected to be ready for filing in 4Q of 2016
Other Markets: Being filed in Ukraine
Olmesartan/HCT Tablets

Approval Status
EU & USA:
Expected to be ready for filing in 4Q of 2016
Clopidogrel + Aspirin Tablets

Approval Status
EU & USA:
Expected to be ready for filing in 4Q of 2016
Dipyridamole Capsules

Approval Status
EU & USA:
Expected to be ready for filing in 1Q of 2017
Dipyridamole/Aspirin Capsules

Approval Status
EU & USA:
Expected to be ready for filing in 1Q of 2017
Olmesartan/Amlodipine Tablets

Approval Status
EU & USA:
Expected to be ready for filing in 4Q of 2016